Huntington’s disease (HD) is a progressive neurodegenerative disease characterized primarily by involuntary movements. Inherited mutations in the huntingtin gene cause a stretch of glutamine residues in its associated protein, huntingtin, to increase in length, so that the mutant protein misfolds and accumulates within neurons. Neurologists believe that failure to clear aggregates of this misfolded protein is an underlying mechanism involved in the onset of HD.
Nerve cells can now be induced to destroy mutant huntingtin protein and reduce aggregate formation, according to the results of a study led by Nobuyuki Nukina of the RIKEN Brain Science Institute in Wako1. The researchers suggest that their approach could be used to effectively treat HD.
Nukina and colleagues used genetic engineering to construct a fusion protein consisting of two copies of polyglutamine binding peptide 1, which is known to bind mutant huntingtin and suppress its aggregation, and the binding regions of heat shock cognate protein 70 (HSC70), which is a ‘chaperone’ protein that targets the mutant huntingtin for destruction.
The researchers found that their construct inhibited the aggregation of mutant huntingtin in cultured cells by inducing a process called chaperone-mediated autophagy, which does not normally break down the misfolded proteins. They also observed that the fusion molecule bound to the mutant huntingtin, forming complexes with HSC70 that were recognized as abnormal and sent to a structure called the lysosome for degradation.
The construct was also effective in clearing aggregates of several other misfolded proteins, including ataxin1, which causes a neurodegenerative disease called spinocerebellar ataxia.
The researchers tested their construct in two strains of mice with HD symptoms. They injected viral vectors containing the construct into the striatum, a brain region that is involved in the control of movement and degenerates in HD patients.
When they examined the animals’ brains four weeks later, they found the construct widely distributed throughout the striatum in both mouse strains. Importantly, the fusion protein had significantly inhibited huntingtin aggregation compared to control mice. As well as reducing the number of aggregates, the construct reduced the average size of the remaining aggregates. The treatment also alleviated HD symptoms in the animals: their movements improved in a behavioral task, they lost less weight, and their survival rate increased.
“Genetic therapy for Huntington's is currently not possible because of the difficulties involved in delivering genes to the brain,” says Nukina, “so we would like to develop or find a compound that can bind to expanded glutamine tracts and HSC70.”
The corresponding author for this highlight is based at the Laboratory for Structural Neuropathology, RIKEN Brain Science Institute
1. Bauer, P.O., Goswami, A., Wong, H.K., Okuno, M., Kurosawa, M., Yamada, M., Miyazaki, H., Matsumoto, G., Kino, Y., Nagai, Y. & Nukina, N. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nature Biotechnology 28, 256–263 (2010)
gro-pr | Research asia research news
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences